HIV 1 News and Research

RSS

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Complementary medicines include products containing herbs, vitamins, minerals, nutritional supplements, homoeopathic medicines, certain aromatherapy products and traditional Chinese medicines. For this reason they are also called herbal, natural or alternative medicines.

26 Feb 2013

Early lymphoid progenitors thrive in an osteoblastic niche: Study

The Children's Medical Center Research Institute at UT Southwestern has deepened the understanding of the environment within bone marrow that nurtures stem cells, this time identifying the biological setting for specialized blood-forming cells that produce the infection-fighting white blood cells known as T cells and B cells.

25 Feb 2013

Kaposi’s sarcoma risk factors revealed

Scientists have uncovered an intriguing relationship between the risk for Kaposi’s sarcoma, smoking, and the use of highly active antiretroviral therapy.

25 Feb 2013

Two USC scientists develop new algorithm to help predict value of DNA sequencing

Two USC scientists have developed an algorithm that could help make DNA sequencing affordable enough for clinics - and could be useful to researchers of all stripes.

25 Feb 2013

Comprehensive portfolio of antiretroviral products from Mylan

Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary in South Africa, Mylan (Proprietary) Limited, has launched a comprehensive portfolio of antiretroviral (ARV) products.

25 Feb 2013

HIV epidemics and extra-couple relationships: an interview with Steve Bellan, University of Texas

The epicentre of the HIV pandemic is in sub-Saharan Africa, though prevalence of infection varies dramatically between countries for reasons not completely understood.

25 Feb 2013

World closer than ever to ending pediatric AIDS

Writing in the Huffington Post's "Global Motherhood" blog, Chip Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, highlights the foundation's "first annual 'Global Champions for a Mother's Fight' gala, an opportunity to honor some of our heroes in the battle against pediatric HIV/AIDS and discuss global change, innovation, and advocacy."

24 Feb 2013

UNAIDS launches online platform to highlight relevant research

"UNAIDS has launched an online platform, UNAIDS Science now, which highlights some of those papers that are particularly relevant to the United Nations high level targets," the agency reports in an article on its webpage.

24 Feb 2013

Widespread ART coverage can reduce risk of HIV infection, increase life expectancy of general population, studies show

"An intensive campaign to combat HIV/AIDS with costly antiretroviral drugs in rural South Africa has increased life expectancy by more than 11 years and significantly reduced the risk of infection for healthy individuals, according to new research," the Los Angeles Times reports.

23 Feb 2013

Evolution of PEPFAR necessary for continued success

PEPFAR has "met or even surpassed most" of its "bold goals," including "saving the lives of millions of people; supporting the scale-up of HIV prevention, care, and treatment; and strengthening systems and policies for the HIV response," Robert Black of the Johns Hopkins Bloomberg School of Public Health writes in a Lancet opinion piece, noting the release of the Institute of Medicine's (IOM) "Evaluation of PEPFAR" on Wednesday.

22 Feb 2013

Viewpoints: Holtz-Eakin and Roy offer prescription to fix health law; Iowa lawmakers opposed to Medicaid expansion should give up their coverage

Over nearly a century, progressives have pressed for a national, single-payer healthcare system. When it comes to health reform, what have conservatives stood for? For far too long, conservatives have failed to coalesce around a long-term vision of what a free-market healthcare system should look like. ... Obamacare is the logical byproduct of this conservative policy neglect.

22 Feb 2013

USP evaluates Raman device's potential to detect counterfeit and substandard medicines

With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.

21 Feb 2013

Proposals, partisan rhetoric fly in countdown to March 1 spending cuts

News outlets report how spending reductions will impact health care programs. Meanwhile, in hopes of creating momentum toward a compromise, Alan Simpson and Erskine Bowles on Tuesday unveiled a $2.4 trillion proposal that includes $600 billion in spending reductions to health-care programs such as Medicare and Medicaid.

21 Feb 2013

Gilead to resolve Viread patent litigation case with Teva

Gilead Sciences, Inc. today announced that Gilead and Teva Pharmaceuticals have reached an agreement in principle to settle the ongoing patent litigation concerning the patents protecting Viread (tenofovir disoproxil fumarate), a treatment for HIV infection and chronic hepatitis B. Under the terms of the settlement, Teva will be allowed to launch a generic version of Viread on December 15, 2017.

20 Feb 2013

Vaccine prices and availability: an interview with Kate Elder, Vaccines Policy Advisor for Médecins Sans Frontières's Access Campaign

One of the key reasons why children are missed by immunization programs, particularly in developing countries where Médecins Sans Frontières (MSF) works, is that the products that we currently have in their present formulation are not well-suited to the places that have the most un-immunized children. These are the most challenging contexts to work in.

19 Feb 2013

Findings add weight to WHO malaria pregnancy guidance

Pregnant women who receive three or more doses of malaria preventive therapy have higher birthweight babies than those who only receive two, conclude the authors of a meta-analysis.

18 Feb 2013

Insights into HIV-1 virion makeup could improve gene therapy

A discovery about how the HIV-1 virion packages genomic RNA may help researchers to improve the efficacy of gene therapy.

18 Feb 2013

Institute of Medicine to release ‘Evaluation of PEPFAR’ on Feb. 20

Evaluation of PEPFAR, a new report from the Institute of Medicine, presents the results of an assessment of the President's Emergency Plan for AIDS Relief as requested by Congress in its reauthorization of funding for the initiative in 2008.

16 Feb 2013

New approach could make gene therapy dramatically more effective for HIV patients

A research team from Case Western Reserve University School of Medicine has discovered an approach that could make gene therapy dramatically more effective for patients.

16 Feb 2013

China's new first lady has ability to influence public health activism

In an opinion piece published on contextChina, Robert O'Brien, a PhD candidate in international relations at the University of Oxford, examines how China's new first lady, acclaimed folk singer Peng Liyuan, might influence public health activism in the country.

15 Feb 2013

HIV 1 News and Research

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Early lymphoid progenitors thrive in an osteoblastic niche: Study

Kaposi’s sarcoma risk factors revealed

Two USC scientists develop new algorithm to help predict value of DNA sequencing

Comprehensive portfolio of antiretroviral products from Mylan

HIV epidemics and extra-couple relationships: an interview with Steve Bellan, University of Texas

World closer than ever to ending pediatric AIDS

UNAIDS launches online platform to highlight relevant research

Widespread ART coverage can reduce risk of HIV infection, increase life expectancy of general population, studies show

Evolution of PEPFAR necessary for continued success

Viewpoints: Holtz-Eakin and Roy offer prescription to fix health law; Iowa lawmakers opposed to Medicaid expansion should give up their coverage

USP evaluates Raman device's potential to detect counterfeit and substandard medicines

Proposals, partisan rhetoric fly in countdown to March 1 spending cuts

Gilead to resolve Viread patent litigation case with Teva

Vaccine prices and availability: an interview with Kate Elder, Vaccines Policy Advisor for Médecins Sans Frontières's Access Campaign

Findings add weight to WHO malaria pregnancy guidance

Insights into HIV-1 virion makeup could improve gene therapy

Institute of Medicine to release ‘Evaluation of PEPFAR’ on Feb. 20

New approach could make gene therapy dramatically more effective for HIV patients

China's new first lady has ability to influence public health activism

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News